Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(R)-Lorcaserin-D4 is an intermediate in the synthesis of Lorcaserin hydrochloride (L469897), which is a highly selective 5-HT2C receptor agonist developed for the treatment of obesity.